The marketing data collected by the Istituto Misurazioni Statistiche (IMS) were computed in order to evaluate the prescription of AEDs over the last four years. On average, 40% of patients are on monotherapy. Out of the total number of prescriptions, PB accounts for 41%, followed by CBZ (17%), VPA (11%) and fixed combinations (11%), while benzodiazepines account for 4% of prescriptions. The prevalence of epilepsy on pharmacological treatments, assessed on the basis of the DDD-method (defined-daily-doses) is 5.1%.
ANALISI DELLE PRESCRIZIONI DI FARMACI ANTIEPILETTICI IN ITALIA NEGLI ULTIMI 4 ANNI / R. Canger, M.P. Canevini, R. Mai, U. Avio, G.C. Monza. - In: BOLLETTINO-LEGA ITALIANA CONTRO L'EPILESSIA. - ISSN 0394-560X. - 66-67(1989), pp. 333-334.
ANALISI DELLE PRESCRIZIONI DI FARMACI ANTIEPILETTICI IN ITALIA NEGLI ULTIMI 4 ANNI
R. CangerPrimo
;M.P. CaneviniSecondo
;
1989
Abstract
The marketing data collected by the Istituto Misurazioni Statistiche (IMS) were computed in order to evaluate the prescription of AEDs over the last four years. On average, 40% of patients are on monotherapy. Out of the total number of prescriptions, PB accounts for 41%, followed by CBZ (17%), VPA (11%) and fixed combinations (11%), while benzodiazepines account for 4% of prescriptions. The prevalence of epilepsy on pharmacological treatments, assessed on the basis of the DDD-method (defined-daily-doses) is 5.1%.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
